2010 ASCO: HSP90 Inhibitor in Refractory Solid Tumors: Phase I Study of AT13387

2010 ASCO: HSP90 Inhibitor in Refractory Solid Tumors: Phase I Study of AT13387

2010 EORTC: Novel Antagonists of XIAP, cIAP1/2 Generated by Fragment Based Drug Discovery

2010 EORTC: Novel Antagonists of XIAP, cIAP1/2 Generated by Fragment Based Drug Discovery

2010 AACR J_S110 is Effective DNA Methylation Inhibitor In vivo and Reduces Tumor Growth

2010 AACR J_S110 is Effective DNA Methylation Inhibitor In vivo and Reduces Tumor Growth

2010 ASH_SGI-110 Preclinical, PK, DNA Methylation of Low Vol Subcutaneous Formulation

2010 ASH_SGI-110 Preclinical, PK, DNA Methylation of Low Vol Subcutaneous Formulation

2010 ESH: Novel Antagonists of XIAP, cIAP1/2 Generated by Fragment Based Drug Discovery

2010 ESH: Novel Antagonists of XIAP, cIAP1/2 Generated by Fragment Based Drug Discovery

2008 ASH_Anti-AML Activity of SGI-110 and SGI-1036, panobinostat Combined Therapy

2008 ASH_Anti-AML Activity of SGI-110 and SGI-1036, panobinostat Combined Therapy